Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Food Industry News Lifeway Foods blocks Danone takeover with poison pill strategy Lifeway Foods, a pioneer in kefir and probiotic products across the United States, made a definitive stand by… byPallavi MadhirajuNovember 9, 2024